Antithrombotic therapy in atrial fibrillation, Br. Med. J, vol.325, pp.1022-1047, 2002. ,
DOI : 10.1201/b14714-23
European Association for Cardio-Thoracic Surgery Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC), European Heart Rhythm Association, pp.2369-429, 2010. ,
Antithrombotic therapy for venous thromboembolic disease. (American College of Chest Physicians evidence-based clinical practice guidelines, pp.454-545, 2008. ,
Guidelines on the management of valvular heart disease: The task force on the management of valvular heart disease of the European Society of Cardiology ,
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation, Annals of Internal Medicine, vol.131, issue.7, pp.492-501, 1999. ,
DOI : 10.7326/0003-4819-131-7-199910050-00003
NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS, The Lancet, vol.326, issue.8454, pp.515-533, 1985. ,
DOI : 10.1016/S0140-6736(85)90459-3
Clinical Pharmacokinetics and Pharmacodynamics of Warfarin, Clinical Pharmacokinetics, vol.11, issue.6, pp.483-504, 1986. ,
DOI : 10.2165/00003088-198611060-00005
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM), Journal of Thrombosis and Thrombolysis, vol.335, issue.Suppl, pp.83-91, 2007. ,
DOI : 10.1007/s11239-006-9022-7
Hemorrhagic Complications of Anticoagulant Treatment, Chest, vol.119, issue.1, pp.108-129, 2001. ,
DOI : 10.1378/chest.119.1_suppl.108S
Admissions to hospital caused by adverse drug reactions: cross sectional incidence study, BMJ, vol.320, issue.7241, p.1036, 2000. ,
DOI : 10.1136/bmj.320.7241.1036
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism, Annals of Internal Medicine, vol.139, issue.11, pp.893-900, 2003. ,
DOI : 10.7326/0003-4819-139-11-200312020-00007
Safety of Treatment with Oral Anticoagulants in the Elderly, Drugs & Aging, vol.14, issue.4, pp.303-315, 1999. ,
DOI : 10.2165/00002512-199914040-00005
Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism, Hematology, vol.2000, issue.1, pp.266-84, 2000. ,
DOI : 10.1182/asheducation-2000.1.266
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin, Annals of Internal Medicine, vol.124, issue.11, pp.970-979, 1996. ,
DOI : 10.7326/0003-4819-124-11-199606010-00004
Bleeding with anticoagulation therapy ??? Who is at risk, and how best to identify such patients, Thrombosis and Haemostasis, vol.102, pp.268-78, 2009. ,
DOI : 10.1160/TH08-11-0730
The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable, Journal of Clinical Neuroscience, vol.9, issue.3, pp.268-72, 2002. ,
DOI : 10.1054/jocn.2001.1018
Oral anticoagulants, Clinics in Geriatric Medicine, vol.17, issue.1, pp.1-13, 2002. ,
DOI : 10.1016/S0749-0690(05)70102-6
Clinical Predictors of Prolonged Delay in Return of the International Normalized Ratio to within the Therapeutic Range after Excessive Anticoagulation with Warfarin, Annals of Internal Medicine, vol.135, issue.6, pp.393-400, 2001. ,
DOI : 10.7326/0003-4819-135-6-200109180-00008
Heparin Bridging Therapy and Bleeding Events in Octogenarian Inpatients with Atrial Fibrillation Starting Anticoagulation: Results of an Ancillary Study, Journal of the American Geriatrics Society, vol.102, issue.6 Suppl ,
DOI : 10.1111/j.1532-5415.2011.03649.x
URL : https://hal.archives-ouvertes.fr/inserm-00707902
Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects, Fundamental & Clinical Pharmacology, vol.324, issue.3, pp.231-237, 2000. ,
DOI : 10.1111/j.1472-8206.2000.tb00021.x
Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide, Pharmaceutical Research, vol.91, issue.9 ,
DOI : 10.1007/s11095-006-9067-5
URL : https://hal.archives-ouvertes.fr/inserm-00189557
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine, vol.90, issue.2 ,
DOI : 10.1016/j.cmpb.2007.12.002
URL : https://hal.archives-ouvertes.fr/inserm-00274332
Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon, Thrombosis and Haemostasis, vol.90, pp.260-266, 2003. ,
DOI : 10.1160/TH02-10-0179
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients*, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.64-78, 1998. ,
DOI : 10.1016/S0009-9236(98)90122-9
Modeling INR Data to Predict Maintenance Fluindione Dosage, Therapeutic Drug Monitoring, vol.20, issue.6, pp.631-639, 1998. ,
DOI : 10.1097/00007691-199812000-00009
Prediction of Fluindione Maintenance Dosage Hampered by Large Intraindividual Variability, Therapeutic Drug Monitoring, vol.22, issue.6, pp.668-75, 2000. ,
DOI : 10.1097/00007691-200012000-00005
A PK-PD model for predicting the impact of CYP2C9 and VKORC1 polymorphisms on fluindione and acenocoumarol during induction therapy, Clin. Pharmacol . Ther, 2011. ,
Changes in plasma protein binding have little clinical relevance, Clinical Pharmacology & Therapeutics, vol.71, issue.3, pp.115-136, 2002. ,
DOI : 10.1067/mcp.2002.121829
Pharmacokinetic Considerations for Digoxin in Older People, The Open Cardiovascular Medicine Journal, vol.5, issue.1, pp.130-135, 2011. ,
DOI : 10.2174/1874192401105010130
Management of oral anticoagulant in clinical practice: a retrospective study of 187 patients, J. Gerontol. A. Biol ,
Difficult??s pour ??quilibrer les antivitamines K chez des personnes tr??s ??g??es hospitalis??es??: ??tude prospective chez 110 patients avec recherche de facteurs de risque de d??s??quilibre, La Presse M??dicale, vol.37, issue.12, pp.1723-1753, 2008. ,
DOI : 10.1016/j.lpm.2008.04.005
Excess antivitamin k in elderly hospitalised patients aged over 70. a one-year prospective survey] [Article in French], Presse Med, vol.32, pp.972-979, 2003. ,
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications, The Lancet, vol.353, issue.9154, pp.717-726, 1999. ,
DOI : 10.1016/S0140-6736(98)04474-2
Genetic and environmental risk factors for oral anticoagulant overdose, European Journal of Clinical Pharmacology, vol.ed, issue.11 ,
DOI : 10.1007/s00228-002-0538-2
Les centres de suivi et de conseil des traitements anticoagulants??: un outil pour diminuer le nombre de complications h??morragiques des antivitamines K, La Revue de M??decine Interne, vol.24, issue.2, pp.75-82, 2003. ,
DOI : 10.1016/S0248-8663(02)00019-X
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment) ,
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2, Nature, vol.427, issue.6974, pp.537-578, 2004. ,
DOI : 10.1038/nature02214
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity, Blood, vol.106, issue.1, pp.135-175, 2005. ,
DOI : 10.1182/blood-2005-01-0341
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Annals of Internal Medicine, vol.130, issue.6, pp.461-70, 1999. ,
DOI : 10.7326/0003-4819-130-6-199903160-00002
Systematic Overview of Warfarin and Its Drug and Food Interactions, Archives of Internal Medicine, vol.165, issue.10, pp.1095-106, 2005. ,
DOI : 10.1001/archinte.165.10.1095
MOdèles NOn LInéairesLInéairesà effets miXtes). MONOLIX group, 2005. ,
R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2004. ,
Diagnosing Model Diagnostics, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.17-20, 2007. ,
DOI : 10.1038/sj.clpt.6100241
Statistical analysis with missing data, 2002. ,
DOI : 10.1002/9781119013563
Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.707, issue.1-2, pp.169-173, 1998. ,
DOI : 10.1016/S0378-4347(97)00587-2
Haplotypes on Transcriptional Regulation and Warfarin Dose, New England Journal of Medicine, vol.352, issue.22, pp.2285-93, 2005. ,
DOI : 10.1056/NEJMoa044503
Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study, Journal of Thrombosis and Haemostasis, vol.128, issue.10, pp.2020-2024, 2007. ,
DOI : 10.1532/IJH97.06082
URL : https://hal.archives-ouvertes.fr/hal-00688300